Martin Shkreli, the drug entrepreneur who defended his decision to raise the price of a life-saving AIDS drug from $13.50 to $750, went quiet Thursday at a Congressional committee, grinning instead of ...

Shkreli, 32, was arrested in New York City by the FBI early Thursday morning. The federal indictment is related to Shkreli’s time managing the MSMB Capital Management hedge fund, as well as his time ...

Turing Pharmaceuticals CEO Martin Shkreli on Friday defended, without apology, his decision to up the price of the drug Daraprim from $3.50 a pill to $750, during an online interview Friday at ...

aTyr Pharma (ATYR) shares remain in focus on Thursday after controversial American investor Martin Shkreli revealed a short position against the biotherapeutics firm. According to Shkreli, investors ...

NEW YORK (AP) — A judge has told “Pharma Bro” Martin Shkreli (SHKREL’-ee) to keep his mouth shut at his securities fraud trial. Prosecutors had sought a gag order after an impromptu gaggle by Shkreli ...

A young man who caused a huge controversy by trying to jack up the price of a life-saving drug is back in the news. Martin Shkreli was arrested this morning and will reportedly be charged with ...

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge. According ...